Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Kim

Showing results (81-90 of 269) with videos related to

Pageof 27
Sort By:
Journal of Hepatology|January 26, 2016
Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infectionProwpanga Udompap, Ajitha Mannalithara, Nae-Yun Heo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 10, 2021
Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal SyndromeAllison Kwong, W Ray Kim, Paul Y Kwo, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Drug therapy: telaprevirMichael D Leise, W Ray Kim, Katherine M Canterbury, et al.
Mayo Clinic Proceedings|January 14, 2014
Management of hepatic encephalopathy in the hospitalMichael D Leise, John J Poterucha, Patrick S Kamath, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 12, 2024
The suggestion of mitigating disparity in the liver transplantation field among ABO blood typeMiho Akabane, Yuki Imaoka, Carlos O Esquivel, et al.
Journal of Hepatology|December 23, 2014
Reply to: "Chronic kidney disease (CKD) and NAFLD: time for awareness and screening"Alina M Allen, W Ray Kim, Julie K Heimbach, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Burden of liver disease in the United States: summary of a workshopW Ray Kim, Robert S Brown, Norah A Terrault, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 28, 2020
Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver DiseaseDeirdre Mladsi, Christine Barnett, Kavita Aggarwal, et al.
Gastroenterology|September 14, 2004
The impact of competing risks on the observed rate of chronic hepatitis C progressionW Ray Kim, John J Poterucha, Joanne T Benson, et al.
Hepatology (Baltimore, Md.)|December 25, 2016
Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapyJennifer A Flemming, W Ray Kim, Carol L Brosgart, et al.
Pageof 27

Showing results (81-90 of 269) with videos related to

Sort By:
Pageof 27
Journal of Hepatology|January 26, 2016
Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infectionProwpanga Udompap, Ajitha Mannalithara, Nae-Yun Heo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 10, 2021
Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal SyndromeAllison Kwong, W Ray Kim, Paul Y Kwo, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Drug therapy: telaprevirMichael D Leise, W Ray Kim, Katherine M Canterbury, et al.
Mayo Clinic Proceedings|January 14, 2014
Management of hepatic encephalopathy in the hospitalMichael D Leise, John J Poterucha, Patrick S Kamath, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 12, 2024
The suggestion of mitigating disparity in the liver transplantation field among ABO blood typeMiho Akabane, Yuki Imaoka, Carlos O Esquivel, et al.
Journal of Hepatology|December 23, 2014
Reply to: "Chronic kidney disease (CKD) and NAFLD: time for awareness and screening"Alina M Allen, W Ray Kim, Julie K Heimbach, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Burden of liver disease in the United States: summary of a workshopW Ray Kim, Robert S Brown, Norah A Terrault, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 28, 2020
Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver DiseaseDeirdre Mladsi, Christine Barnett, Kavita Aggarwal, et al.
Gastroenterology|September 14, 2004
The impact of competing risks on the observed rate of chronic hepatitis C progressionW Ray Kim, John J Poterucha, Joanne T Benson, et al.
Hepatology (Baltimore, Md.)|December 25, 2016
Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapyJennifer A Flemming, W Ray Kim, Carol L Brosgart, et al.
Pageof 27